169 related articles for article (PubMed ID: 25247996)
1. Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.
Huang YC; Wei KC; Chang CN; Chen PY; Hsu PW; Chen CP; Lu CS; Wang HL; Gutmann DH; Yeh TH
PLoS One; 2014; 9(9):e108228. PubMed ID: 25247996
[TBL] [Abstract][Full Text] [Related]
2. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
[TBL] [Abstract][Full Text] [Related]
3. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas.
Johnson MD; O'Connell M; Vito F; Bakos RS
J Neurooncol; 2009 Apr; 92(2):129-36. PubMed ID: 19034385
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Shan H; Zhou X; Chen C
Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase as a novel target for meningioma therapy.
Haase D; Schmidl S; Ewald C; Kalff R; Huebner C; Firsching R; Keilhoff G; Evert M; Paulus W; Gutmann DH; Lal A; Mawrin C
Neuro Oncol; 2010 Aug; 12(8):844-54. PubMed ID: 20511185
[TBL] [Abstract][Full Text] [Related]
6. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
Das A; Alshareef M; Henderson F; Martinez Santos JL; Vandergrift WA; Lindhorst SM; Varma AK; Infinger L; Patel SJ; Cachia D
Clin Transl Oncol; 2020 Jul; 22(7):1138-1145. PubMed ID: 31732915
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
9. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.
Johnson MD; O'Connell M; Pilcher W
J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751
[TBL] [Abstract][Full Text] [Related]
10. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase activity in human brain tumors.
Röhn G; Ernestus RI; Schröder R; Hossmann KA; Klug N; Paschen W
Acta Histochem Suppl; 1992; 42():155-8. PubMed ID: 1350103
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis.
Harb OA; Elsayed WS; Ismail EI; Toam MM; Ammar MG
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2299-2308. PubMed ID: 28843270
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.
Johnson MD; O'Connell M; Facik M; Maurer P; Jahromi B; Pilcher W
J Neurooncol; 2012 Mar; 107(1):121-31. PubMed ID: 21971737
[TBL] [Abstract][Full Text] [Related]
15. Mast cells evaluation in meningioma of various grades.
Reszec J; Hermanowicz A; Kochanowicz J; Turek G; Mariak Z; Chyczewski L
Folia Histochem Cytobiol; 2012; 50(4):542-6. PubMed ID: 23264217
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic impact of ornithine decarboxylase in meningiomas.
Stenzel W; Röhn G; Miletic H; Radner H; Deckert M; Ernestus RI
J Neurooncol; 2004 Jan; 66(1-2):59-64. PubMed ID: 15015770
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
Wallesch M; Pachow D; Blücher C; Firsching R; Warnke JP; Braunsdorf WEK; Kirches E; Mawrin C
J Neurol Sci; 2017 Sep; 380():112-121. PubMed ID: 28870549
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas.
Kitange G; Tsunoda K; Anda T; Nakamura S; Yasunaga A; Naito S; Shibata S
Cancer; 2000 Dec; 89(11):2292-300. PubMed ID: 11147600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
